SCHEMBL14093085

SCHEMBL14093085

CC(C)(C)C1CNCc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
KMT2A Q03164 1/20 0.51
HTR2A P28223 2/20 0.44
HTR2C P28335 2/20 0.40
HTR2B P41595 1/20 0.40
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
PNMT P11086 1/20 0.35
CD44 P16070 1/20 0.35
MAOB P27338 1/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNA7 P36544 1/20 0.35
TAOK1 Q7L7X3 1/20 0.33
TAOK3 Q9H2K8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15912365 0.76 CHRNB2 (0.37) CYP2D6HTR2AHTR2CHTR2BALDH1A1
SCHEMBL329949 0.75 HTR2C (0.67) MEN1CYP3A4CYP2D6KMT2AHTR2A
SCHEMBL329759 0.75 HTR2C (0.67) MEN1CYP3A4CYP2D6KMT2AHTR2A
SCHEMBL329626 0.75 HTR2C (0.67) MEN1CYP3A4CYP2D6KMT2AHTR2A
SCHEMBL31159134 0.75 HTR2C (0.67) MEN1CYP3A4CYP2D6KMT2AHTR2A
SCHEMBL23308861 0.74 MEN1 (0.47) MEN1CYP3A4CYP2D6KMT2AHTR2A
SCHEMBL10383840 0.74 MEN1 (0.44) MEN1CYP3A4CYP2D6KMT2AHTR2A
Hydrochloric Acid SCHEMBL38653867 0.73 HTR2C (0.65) MEN1CYP3A4CYP2D6KMT2AHTR2A
Hydrochloric Acid SCHEMBL2259898 0.73 HTR2C (0.65) MEN1CYP3A4CYP2D6KMT2AHTR2A
Hydrochloric Acid SCHEMBL38652787 0.73 HTR2C (0.65) MEN1CYP3A4CYP2D6KMT2AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417053-B2 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof TEIJIN PHARMA LIMITED (JP) 2008-08-26 US disclosed
US-7417053-B2 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof TEIJIN PHARMA LIMITED (JP) 2008-08-26 US disclosed
US-20070072898-A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof TEIJIN PHARMA LIMITED 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072898-A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof MAPKAPK2, MAP4K2, MAPKAPK5 MEN1 1274/4885CYP3A4 4215/4885CYP2D6 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.